Weekly Top Ten News Stories – 16 October 2020

Extra Edition of the Broker Call Report

Blood plasma collections have declined globally in the face of the pandemic. Should CSL investors be concerned?

Michael Gable of Fairmont Equities suggests that after suffering in September, ResMed is offering a buying opportunity.

The infrastructure splurge in the latest federal budget augurs well for Downer EDI, Australia's largest road construction and maintenance provider. Morgan Stanley upgrades to Overweight.

Weekly Broker Wrap: Three positive components in the federal budget sure to benefit the banking sector; Morgan Stanley prefers diversified over pure-play iron ore stocks; higher import volumes expected for ammonium nitrate.

In this week’s Weekly Insights:-Market Momentum Switch: A Messy Affair-Conviction Calls-Dividend Traps & OpportunitiesThe Economic Recovery, A Messy AffairBy Rudi Filapek-Vandyck, Editor FNArenaUnder more “normal” circumstances, we’d all be talk

Weekly update on stockbroker recommendation, target price, and earnings forecast changes.

The New Criterion's Tim Boreham thinks it may be some time before investors are able to sort the wheat from the chaff in Australia's BNPL sector

Commonwealth Bank's retail and business divisions rank highly and, Bell Potter believes, should justify a premium to other major banks. Other brokers are not so convinced.

Peter Switzer of the Switzer Report highlights several small cap companies you've likely never heard of.